The central role of thrombin in bleeding disorders.

[1]  C. Négrier,et al.  Emicizumab should be prescribed independent of immune tolerance induction. , 2018, Blood advances.

[2]  J. Heemskerk,et al.  Integrating platelet and coagulation activation in fibrin clot formation , 2018, Research and practice in thrombosis and haemostasis.

[3]  A. Lienhart,et al.  Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab , 2018, Haematologica.

[4]  E K Waters,et al.  Concizumab, an anti‐tissue factor pathway inhibitor antibody, induces increased thrombin generation in plasma from haemophilia patients and healthy subjects measured by the thrombin generation assay , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  H. Hemker,et al.  Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH , 2017, Journal of thrombosis and haemostasis : JTH.

[6]  J. Oldenburg,et al.  Emicizumab Prophylaxis in Hemophilia A with Inhibitors , 2017, The New England journal of medicine.

[7]  A. Akinc,et al.  Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy , 2017, The New England journal of medicine.

[8]  J. Burthem,et al.  Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  J. Huntington,et al.  Design and characterization of an APC-specific serpin for the treatment of hemophilia. , 2017, Blood.

[10]  Flora Peyvandi,et al.  The past and future of haemophilia: diagnosis, treatments, and its complications , 2016, The Lancet.

[11]  Tetsuji Sato,et al.  Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A. , 2016, The New England journal of medicine.

[12]  J. Oldenburg,et al.  A critical appraisal of one‐stage and chromogenic assays of factor VIII activity , 2016, Journal of thrombosis and haemostasis : JTH.

[13]  R. Montgomery,et al.  Comparison of platelet‐derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay , 2015, Journal of thrombosis and haemostasis : JTH.

[14]  S. Lethagen,et al.  Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial , 2015, Journal of thrombosis and haemostasis : JTH.

[15]  S. Milstein,et al.  An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia , 2015, Nature Medicine.

[16]  H. Brinkman.  Global assays and the management of oral anticoagulation , 2015, Thrombosis Journal.

[17]  A. Hillarp,et al.  One‐stage vs. chromogenic assays in haemophilia A , 2015, European journal of haematology.

[18]  M. Lancé.  A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis , 2015, Thrombosis Journal.

[19]  M. Karimi,et al.  Evaluation of Thrombin Generation Assay in Patients With Hemophilia , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[20]  V. Laux,et al.  Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94‐9027) for haemophilia A , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[21]  K. Brummel-Ziedins,et al.  Developing individualized coagulation profiling of disease risk: thrombin generation dynamic models of the pro and anticoagulant balance. , 2014, Thrombosis research.

[22]  H. Mani,et al.  Main considerable factors for correct laboratory test interpretation under DOA treatment , 2013, Thrombosis Journal.

[23]  J. Thachil,et al.  Towards standardization of clot waveform analysis and recommendations for its clinical applications , 2013, Journal of thrombosis and haemostasis : JTH.

[24]  S. Krishnaswamy.  The transition of prothrombin to thrombin , 2013, Journal of thrombosis and haemostasis : JTH.

[25]  T. Orfeo,et al.  From Principle to Practice: Bridging the Gap in Patient Profiling , 2013, PloS one.

[26]  R. van Oerle,et al.  Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method , 2012, Journal of thrombosis and haemostasis : JTH.

[27]  T. Orfeo,et al.  Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia. , 2012, Thrombosis research.

[28]  K. Mann,et al.  Is there value in kinetic modeling of thrombin generation? Yes , 2012, Journal of thrombosis and haemostasis : JTH.

[29]  Y. Dargaud,et al.  Mechanisms and monitoring of bypassing agent therapy , 2012, Journal of thrombosis and haemostasis : JTH.

[30]  G. Barillari,et al.  Whole blood rotation thromboelastometry (ROTEM®) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[31]  M. Feuring,et al.  Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran , 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[32]  C. Danforth,et al.  Defining the Boundaries of Normal Thrombin Generation: Investigations into Hemostasis , 2012, PloS one.

[33]  K. Mann.  Thrombin generation in hemorrhage control and vascular occlusion. , 2011, Circulation.

[34]  R. Schaub,et al.  Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor. , 2011, Blood.

[35]  M. Makris,et al.  The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies , 2011, International journal of laboratory hematology.

[36]  A. Lienhart,et al.  Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery. , 2010, Blood.

[37]  C. Ruan,et al.  Hyperfibrinogenemia and prolonged clotting times in a Turner syndrome patient with hepatocellular carcinoma , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[38]  S. Nair,et al.  Tests of global haemostasis and their applications in bleeding disorders , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[39]  A. Wolberg,et al.  Plasma and cellular contributions to fibrin network formation, structure and stability , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[40]  J. Astermark,et al.  Thrombin generation in vitro in the presence of by‐passing agents in siblings with severe haemophilia A , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[41]  K. Mann,et al.  Thrombin generation and bleeding in haemophilia A , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[42]  Kenichi A Tanaka,et al.  Blood Coagulation: Hemostasis and Thrombin Regulation , 2009, Anesthesia and analgesia.

[43]  J. Thachil,et al.  Guidelines for the diagnosis and management of disseminated intravascular coagulation , 2009, British journal of haematology.

[44]  G. Lippi,et al.  Thrombin generation assay: a useful routine check‐up tool in the management of patients with haemophilia? , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[45]  S. Moll,et al.  Inherited antithrombin deficiency: a review , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[46]  E. Berntorp,et al.  Standardization and clinical utility of thrombin-generation assays. , 2008, Seminars in thrombosis and hemostasis.

[47]  M. Prins,et al.  Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory , 2008, Thrombosis and Haemostasis.

[48]  W. V. van Heerde,et al.  Diagnosis of factor VIII deficiency , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[49]  Tomoko Matsumoto,et al.  New assays for monitoring haemophilia treatment , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[50]  C. Négrier,et al.  Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[51]  A. Srivastava,et al.  The phenotypic heterogeneity of severe hemophilia. , 2008, Seminars in thrombosis and hemostasis.

[52]  Alisa S Wolberg,et al.  Thrombin generation, fibrin clot formation and hemostasis. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[53]  S. Béguin,et al.  Thrombin-generating capacity in patients with von Willebrand’s disease , 2007, Haematologica.

[54]  H. Alexander,et al.  The impact of major surgery on blood coagulation factors and thrombin generation , 2007, American journal of hematology.

[55]  D. Lane,et al.  The central role of thrombin in hemostasis , 2007, Journal of thrombosis and haemostasis : JTH.

[56]  G. Young,et al.  Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[57]  A. Giles,et al.  The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay , 2006, Journal of thrombosis and haemostasis : JTH.

[58]  F. Depasse,et al.  Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay , 2005, Thrombosis journal.

[59]  J. Ingerslev,et al.  Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one‐stage clotting assays , 2004, Journal of thrombosis and haemostasis : JTH.

[60]  J. Whisstock,et al.  Antithrombin: in control of coagulation. , 2004, The international journal of biochemistry & cell biology.

[61]  J. Ingerslev,et al.  Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa , 2004, Journal of thrombosis and haemostasis : JTH.

[62]  Maureane Hoffman,et al.  Remodeling the Blood Coagulation Cascade , 2003, Journal of Thrombosis and Thrombolysis.

[63]  K. Pasi,et al.  Haemophilias A and B , 2003, The Lancet.

[64]  D. Monroe,et al.  Platelets and thrombin generation. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[65]  D. Monroe,et al.  Coagulation Factor Interaction with Platelets , 2002, Thrombosis and Haemostasis.

[66]  M. Laposata,et al.  Laboratory diagnosis of dysfibrinogenemia. , 2002, Archives of pathology & laboratory medicine.

[67]  A. Giles,et al.  The Utility of activated Partial Thromboplastin Time (aPTT) Clot Waveform Analysis in the Investigation of Hemophilia A Patients with very Low Levels of Factor VIII Activity (FVIII:C) , 2002, Thrombosis and Haemostasis.

[68]  K. Mann,et al.  "Normal" thrombin generation. , 1999, Blood.

[69]  C. Kessler,et al.  Influence of phospholipids on the assessment of factor VIII activity , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[70]  W. Heil,et al.  Influence of Time and Temperature on Coagulation Analytes in Stored Plasma , 1998, Clinical chemistry and laboratory medicine.

[71]  A. Stead,et al.  Properties of Optical Data from Activated Partial Thromboplastin Time and Prothrombin Time Assays , 1997, Thrombosis and Haemostasis.

[72]  M. Hoffman,et al.  Variability in platelet procoagulant activity in healthy volunteers. , 1996, Thrombosis research.

[73]  G. Broze.  Tissue factor pathway inhibitor and the current concept of blood coagulation , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[74]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[75]  C. Kitchens.  Prolonged activated partial thromboplastin time of unknown etiology: A prospective study of 100 consecutive cases referred for consultation , 1988, American journal of hematology.

[76]  C. Esmon,et al.  Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C. , 1984, The Journal of biological chemistry.

[77]  J. Griffin,et al.  Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. , 1984, Blood.

[78]  Macfarlane Rg,et al.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .

[79]  M. Seeberger,et al.  Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. , 2012, Transfusion medicine reviews.

[80]  T. Orfeo,et al.  Blood coagulation dynamics in haemostasis , 2009, Hämostaseologie.

[81]  H. Hemker,et al.  Thrombin generation, a function test of the haemostaticthrombotic system , 2006, Thrombosis and Haemostasis.

[82]  Dougald M Monroe,et al.  What does it take to make the perfect clot? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[83]  H. Hemker,et al.  Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B , 2005, Thrombosis and Haemostasis.

[84]  M. Shima.  Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis. , 2004, Seminars in hematology.

[85]  M. Greaves,et al.  Role of coagulation testing in predicting bleeding risk. , 2003, The hematology journal : the official journal of the European Haematology Association.

[86]  Flora Peyvandi,et al.  The Thrombogram in Rare Inherited Coagulation Disorders: Its Relation to Clinical Bleeding , 2002, Thrombosis and Haemostasis.

[87]  J. Jespersen,et al.  A study of the conditions and accuracy of the thrombin time assay of plasma fibrinogen. , 1982, Acta haematologica.